Scientific Excellence
QbD-driven R&D by experienced scientists pushing pharma innovation boundaries.
About
Avidia Pharma Labs LLP specialises in oral dosage forms and injectable formulations, supporting clients from concept through regulatory filing with integrated CRO + CDMO services.
Who we are
Avidia Pharma Labs LLP specialises in oral dosage forms and injectable formulations, supporting clients from concept through regulatory filing with integrated CRO + CDMO services.
Our portfolio serves the US, Europe, and ROW markets — spanning cardiovascular, anticancer, antidiabetic, neurology, antibiotics and more.
IR, SR, CR, enteric-coated tablets & capsules, solutions, suspensions, and syrups.
Solutions, suspensions, lyophilized products, and peptides — including oncology injectables.
Therapeutic categories
Vision
Mission
Core pillars
QbD-driven R&D by experienced scientists pushing pharma innovation boundaries.
GMP/cGMP and ICH-compliant, audit-ready at every development stage.
Deep US FDA & EU EMA expertise ensuring smooth global submissions.
Novel formulations, 505(b)(2) and oncology programs driven by bold IP creation.
Transparent, tailored collaboration — from startup to global pharma leader.
Leadership
Get in touch
Whether it's an early-stage formulation challenge, a 505(b)(2) program, or a commercial tech transfer — we'd be glad to talk through how we can help.